Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG2 | P78540 | 9/20 | 0.60 |
| ▸ | ARG1 | P05089 | 8/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15664945 | 0.90 | ARG2 (0.64) | ARG2ARG1CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL30169846 | 0.83 | ARG1 (0.60) | ARG2ARG1 | |
| SCHEMBL11650757 | 0.82 | ARG1 (0.58) | ARG2ARG1CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL4406496 | 0.82 | ARG1 (0.58) | ARG2ARG1CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL31042217 | 0.82 | ARG1 (0.59) | ARG2ARG1 | |
| SCHEMBL31042229 | 0.82 | ARG1 (0.59) | ARG2ARG1 | |
| SCHEMBL31042202 | 0.82 | ARG1 (0.59) | ARG2ARG1 | |
| SCHEMBL31042199 | 0.82 | ARG1 (0.59) | ARG2ARG1 | |
| SCHEMBL22338400 | 0.81 | ARG2 (0.91) | ARG2ARG1 | |
| SCHEMBL31106404 | 0.80 | ARG1 (0.47) | ARG2ARG1CYP2D6SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024102421-A2 | COMPOUNDS, COMPLEXES, AND METHODS FOR THEIR PREPARATION AND OF THEIR USE | Revolution Medicines, Inc. (US) | 2024-05-16 | — | — | WO | disclosed |
| EP-3607326-A1 | METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES | Revolution Medicines, Inc. (US) | 2020-02-12 | — | — | EP | disclosed |
| EP-3606492-A1 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | Revolution Medicines, Inc. (US) | 2020-02-12 | — | — | EP | disclosed |
| WO-2018187423-A1 | METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES | WARP DRIVE BIO, INC. (US) | 2018-10-11 | — | — | WO | disclosed |
| WO-2018187401-A1 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | WARP DRIVE BIO, INC. (US) | 2018-10-11 | — | — | WO | disclosed |
| EP-3355930-A1 | METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES | Warp Drive Bio, Inc. (US) | 2018-08-08 | — | — | EP | disclosed |
| EP-3247378-A1 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | Warp Drive Bio, Inc. (US) | 2017-11-29 | — | — | EP | disclosed |
| EP-3247377-A1 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | Warp Drive Bio, Inc. (US) | 2017-11-29 | — | — | EP | disclosed |
| WO-2016112295-A1 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | WARP DRIVE BIO, INC. (US) | 2016-07-14 | — | — | WO | disclosed |
| WO-2016112279-A1 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | WARP DRIVE BIO, INC. (US) | 2016-07-14 | — | — | WO | disclosed |
| EP-0719779-B1 | SUBSTITUTED THIAZOLO [3,2-ALPHA]AZEPINE DERIVATIVE | EISAI CO LTD (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-6051705-A | HAVING INHIBITORY ACTIVITY AGAINST ANGIOTENSIN I CONVERTING ENZYME AND NEUTRAL ENDPEPTIDASE | EISAI CO., LTD. (JP) | 2000-04-18 | — | — | US | disclosed |
| US-5789403-A | PEPTIDASE AND ACE ENZYME INHIBITORS | EISAI CO., LTD. (JP) | 1998-08-04 | — | — | US | disclosed |
| EP-0784603-A2 | RACEMISATION OF PRECURSORS TO LEVOBUPIVACAINE AND ANALOGUES THEREOF | Chiroscience Limited (GB) | 1997-07-23 | — | — | EP | disclosed |
| EP-0719779-A1 | SUBSTITUTED THIAZOLO [3,2-ALPHA]AZEPINE DERIVATIVE | Eisai Co., Ltd. (JP) | 1996-07-03 | — | — | EP | disclosed |
| WO-1996011173-A2 | RACEMISATION OF PRECURSORS TO LEVOBUPIVACAINE AND ANALOGUES THEREOF | CHIROSCIENCE LIMITED (GB) | 1996-04-18 | — | — | WO | disclosed |